An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]
Liquid biopsy has the promise to revolutionise cancer care and treatment, allowing the detection of rare cell types with a […]
Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]
A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]
Researchers have validated the use of circulating tumour DNA (ctDNA) and metabolites in cerebrospinal fluid (CSF) as potential biomarkers for […]
The “liquid” in liquid biopsy most commonly refers to blood. However, the human body contains many other fluids and biological […]
The most common analytes in liquid biopsies are CTCs and ctDNA. However, there is so much more that can be […]
Liquid biopsy has seen a lot of development and many applications in the field of cancer diagnostics. Key applications include […]
Obtaining an effective diagnosis is the crucial first step in the treatment of cancer and many other diseases. Unfortunately, invasive […]
Liquid biopsy offers an innovative solution for the diagnosis and monitoring of cancer and other diseases. However, traditional invasive biopsy […]
